The most notable difference between our results and those of Hollander et al. was the role of Akt2 as a putative tumor suppressor, such that deletion of Akt2 more than tripled lung tumor multiplicity and increased tumor initiation in our viral oncogene-induced mouse model of lung cancer. Here, AKT2 is linked to lung carcinoma.